Citadel Advisors - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 14 filers reported holding VIKING THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,175,953
-63.5%
557,900
-46.6%
0.00%
-66.7%
Q2 2023$16,928,379
-2.2%
1,044,317
+0.5%
0.00%
-25.0%
Q1 2023$17,304,212
+185.8%
1,039,292
+61.4%
0.00%
+300.0%
Q4 2022$6,054,126
+1227.7%
644,056
+285.3%
0.00%
Q3 2022$456,000
-33.2%
167,147
-29.2%
0.00%
Q2 2022$683,000
-70.0%
236,250
-68.8%
0.00%
Q1 2022$2,273,000
+27.0%
757,845
+94.8%
0.00%
Q4 2021$1,790,000
-16.8%
389,099
+13.5%
0.00%
Q3 2021$2,152,000
-9.4%
342,745
-13.6%
0.00%
Q2 2021$2,375,000
+27.6%
396,530
+34.8%
0.00%
Q1 2021$1,861,000
-39.3%
294,199
-46.0%
0.00%
Q4 2020$3,066,000
+14.6%
544,570
+18.4%
0.00%
Q3 2020$2,676,000
-7.7%
459,934
+14.5%
0.00%
-100.0%
Q2 2020$2,898,000
+34.8%
401,808
-12.6%
0.00%0.0%
Q1 2020$2,150,000
-58.0%
459,508
-28.1%
0.00%
-66.7%
Q4 2019$5,122,000
+40.6%
638,700
+20.7%
0.00%
+200.0%
Q3 2019$3,642,000
-30.8%
529,300
-16.6%
0.00%
-66.7%
Q2 2019$5,265,000
-68.3%
634,311
-62.1%
0.00%
-62.5%
Q1 2019$16,631,000
+49.0%
1,673,174
+14.7%
0.01%
+33.3%
Q4 2018$11,163,000
-56.0%
1,459,245
+0.3%
0.01%
-45.5%
Q3 2018$25,342,000
+236.8%
1,454,701
+83.5%
0.01%
+266.7%
Q2 2018$7,524,000
+11475.4%
792,871
+5194.6%
0.00%
Q1 2018$65,000
-39.8%
14,975
-73.5%
0.00%
Q3 2017$108,000
+414.3%
56,461
+239.6%
0.00%
Q2 2016$21,000
+10.5%
16,624
+27.4%
0.00%
Q1 2016$19,00013,0440.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders